Skip to content

Comparing the beneficial effects of patients own Platelet rich plasma therapy and topical minoxidil 5%lotion in males with hairloss problems due to male hormones.

Comparison of efficacy of Autologous Platelet rich plasma therapy versus topical minoxidil 5% in males with Androgenetic alopecia: a randomized open label trial with blinded outcome assessment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025389
Enrollment
70
Registered
2020-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

Intervention1: 5% Minoxidil: 5% Minoxidil lotion is given to the patients and advised to apply 1ml of lotion twice daily over the scalp for 6 months.at end of 6 months response to minoxidil is measure

Sponsors

Jawaharlal Institute of Postgraduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consenting consecutive males with Grade III-IV Andogenetic alopecia of modified Hamilton Norwood scale aged 20-49 years (The diagnosis of AGA will be established on the basis of clinical and trichoscopic features of more than 20% variability in hair diameter between affected and uninvolved areas; extent will be assessed according to the Modified Hamilton Norwood classification assessed by an experienced dermatologist (co-guide))

Exclusion criteria

Exclusion criteria: 1.Dermatological disease of the scalp. 2.Patient who has tendency to form keloid. 3.Patient who had received medical/surgical treatment in the previous 6 months 4.Bone marrow aplasia 5.Platelet disorders, patients on antiaggregating and anticoagulant therapy, 6.Uncompensated diabetes mellitus, sepsis, cancer, immunosuppression. 7.Allergy to anaesthetics

Design outcomes

Primary

MeasureTime frame
1.Proportion of responders using Global photographic assessment 2.Mean change in scalp target area non-vellus hair count, hair density and proportion of anagen hairs based on standardized phototrichogram Timepoint: 1.At baseline and end of 24 weeks 2.At baseline and end of 12 weeks

Secondary

MeasureTime frame
1.To compare scalp target area non-vellus hair count and hair density based on standardized phototrichogram the end of 6 months. 2.To compare the side effect profile between the two groups. 3.To compare the Patient satisfaction score between the two groups at the end of 3 months and 6 months Timepoint: 1.At baseline ,after 12 weeks and end of 24 weeks. 2.side effect profile- at every 4 weeks till 6 months 3.Patient satisfaction score at 12weeks & 24 weeks

Countries

India

Contacts

Public ContactMITHIN KUMAR B

Jawaharlal Institute of Post-graduate Medical Education and Research.

siva11rsamy@yahoo.com9994085511

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026